| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0735-1097(00)00743-9 |
| P698 | PubMed publication ID | 10933350 |
| P50 | author | John E. Deanfield | Q87879115 |
| P2093 | author name string | D Wright | |
| H Thomson | |||
| S Thorne | |||
| A E Donald | |||
| M J Mullen | |||
| P2860 | cites work | Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure | Q28297273 |
| Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes | Q34180296 | ||
| Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. | Q34223377 | ||
| Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors | Q34463540 | ||
| Inactivation of endothelial derived relaxing factor by oxidized lipoproteins | Q35595749 | ||
| Lipid advanced glycosylation: pathway for lipid oxidation in vivo | Q36412583 | ||
| Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility | Q36823491 | ||
| Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. | Q37354435 | ||
| The vascular effects of L-Arginine in humans. The role of endogenous insulin | Q37363072 | ||
| Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury | Q37542333 | ||
| Glaxo/MRS Young Investigator Prize. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus | Q40517249 | ||
| Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes | Q41022241 | ||
| Statins do more than just lower cholesterol | Q41169571 | ||
| Atherosclerosis and the two faces of endothelial nitric oxide synthase | Q41690339 | ||
| Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus | Q44553205 | ||
| Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level | Q47357190 | ||
| Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo | Q49137523 | ||
| Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine. | Q54131232 | ||
| Flow-induced dilatation in isolated resistance arteries from control and streptozotocin-diabetic rats. | Q54145020 | ||
| Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. | Q54225577 | ||
| Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication | Q57791545 | ||
| Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic Rabbits | Q63184888 | ||
| Diabetes and cardiovascular risk factors: the Framingham study | Q67462912 | ||
| Endothelium-dependent relaxation in aorta of BB rat | Q69057817 | ||
| The effect of high glucose on polyol pathway activity and myoinositol metabolism in cultured human endothelial cells | Q69665485 | ||
| Regression or progression. Dependency on vascular nitric oxide | Q70865457 | ||
| Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels | Q71442222 | ||
| Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase | Q71667001 | ||
| Restoration of vascular endothelial function in diabetes | Q71670000 | ||
| Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or non-specific effect? | Q71731726 | ||
| Close relation of endothelial function in the human coronary and peripheral circulations | Q71827302 | ||
| Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial | Q72198055 | ||
| Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium | Q72285314 | ||
| Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria | Q72722829 | ||
| Arginine: a new therapy for atherosclerosis? | Q73012571 | ||
| Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins. Cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation | Q73047649 | ||
| Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) | Q73209707 | ||
| The association of reduced endothelium derived relaxing factor-NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus | Q73397576 | ||
| Endothelial dysfunction of conduit arteries in insulin-dependent diabetes mellitus without microalbuminuria | Q73499512 | ||
| High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells | Q73542912 | ||
| Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo | Q74561887 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type-1 diabetes | Q124407 |
| P304 | page(s) | 410-416 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study | |
| P478 | volume | 36 |
| Q35603932 | ADMA and oxidative stress |
| Q35547296 | Agents that stabilise atherosclerotic plaque |
| Q33886380 | Altering dietary lysine:arginine ratio has little effect on cardiovascular risk factors and vascular reactivity in moderately hypercholesterolemic adults |
| Q44932061 | Anti-apoptotic effect of atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardiac myocytes through protein kinase C activation |
| Q90597664 | Arginine impairs endothelial and executive function in older subjects with cardiovascular risk |
| Q35549944 | Assessing endothelial function as a risk factor for cardiovascular disease |
| Q35989422 | Atorvastatin: a review of its use in the primary prevention of cardiovascular events in patients with type 2 diabetes mellitus |
| Q34427770 | Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia |
| Q38005031 | Cardiovascular disease risk in young people with type 1 diabetes. |
| Q36081210 | Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins |
| Q34030500 | Determinants of vascular phenotype in a large childhood population: the Avon Longitudinal Study of Parents and Children (ALSPAC). |
| Q35762905 | Effect of atorvastatin on ocular blood flow velocities in patients with diabetic retinopathy |
| Q79882298 | Effect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease |
| Q34401762 | Effect of diet on vascular reactivity: an emerging marker for vascular risk |
| Q44675894 | Effects of Atorvastatin on LDL sub-fractions and peroxidation in type 1 diabetic patients: a randomised double-blind placebo-controlled study |
| Q36957799 | Effects of atorvastatin on the different phases of atherogenesis |
| Q35077217 | Effects of statins on the vasculature: Implications for aggressive lipid management in the cardiovascular metabolic syndrome |
| Q35087390 | Endothelial dysfunction in human diabetes |
| Q33620009 | Farnesyltransferase inhibitor improved survival following endotoxin challenge in mice |
| Q24202363 | Lipid lowering efficacy of atorvastatin |
| Q24187301 | Lipid-lowering efficacy of atorvastatin |
| Q37030681 | Microcirculation and oxidative stress |
| Q35023979 | Miscellaneous medications for the management of atherosclerosis: mayhem or miracle? |
| Q35233396 | Nutritional programming of pancreatic β-cell plasticity |
| Q44613104 | Rapid Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition on Coronary Endothelial Function |
| Q37154728 | Scientific rationale for combination of a calcium channel antagonist and an HMG-CoA reductase inhibitor: a new approach to risk factor management |
| Q53064414 | Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus. |
| Q44551854 | Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin |
| Q36088110 | Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. |
| Q36529299 | The effect of L-arginine on arterial stiffness and oxidative stress in chronic kidney disease |
| Q82636190 | The effect of simvastatin on asymmetric dimethylarginine and flow-mediated vasodilation after optimizing the LDL level: a randomized, placebo-controlled study |
| Q46081694 | The impact of oral L-arginine supplementation on acute smoking-induced endothelial injury and arterial performance. |
| Q33870395 | Therapeutic interventions and oxidative stress in diabetes |
| Q44323037 | Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus |
| Q35087606 | Vascular reactivity in diabetes mellitus |
| Q52552525 | [Atheroma plaque stabilization: a new concept based on the dynamic biology of atherosclerosis]. |
Search more.